To determine the immunological response to IDO1 inhibitors, tumor tissue obtained from internal sacrifice on day five was analyzed using flow cytometry to observe changes in immune cell populations after drug treatment (Figure 1G). The gene discussed is IDO1; the disease is neoplasm.